0001590364-25-000023
SEC filingNotes highlight strong aerospace products revenue growth and segment profitability, with total debt stable and dividends maintained.
Cash and cash equivalents rose to $301.9M as of June 30, 2025, from $115.1M at year-end 2024, driven by investing activities and debt rollover. Total debt net of issuance costs was $3,444.6M, unchanged from $3,440.5M at December 31, 2024, with no material net borrowings. Shareholders' equity increased to $164.9M from $81.4M, reflecting net income of $267.8M partially offset by dividends and preferred share redemptions. Inventory increased to $752.9M from $551.2M, supporting Aerospace Products growth.
The Notes disclose a contingent obligation in the offshore energy business with a maximum potential loss of $3.3M, considered remote. No other significant purchase commitments or contractual obligations were detailed. Operating lease minimum future revenues total $595.3M, but these are revenue expectations, not commitments.
Dividends: Ordinary dividends totaled $61.5M in H1 2025, with a stable quarterly rate of $0.30 per share. Preferred dividends were $9.8M. No share buybacks were authorized or executed. Debt activity was limited to $430M in proceeds and repayments, resulting in net zero change. Capital expenditures were $423.2M, primarily for leasing equipment acquisition, representing 35.9% of sales.
Aviation Leasing generated $323.0M revenue (flat YoY) with operating income of $227.3M, boosted by gains on asset sales to the 2025 Partnership. Aerospace Products revenue surged 97% to $855.3M, driven by MRE contracts and higher product sales, with operating income of $285.4M. Geographically, North America (primarily US) contributed 47% of total revenue, Europe 32%, Asia 14%, and other regions 7%. Long-lived assets are concentrated in Europe (39%) and North America (28%).
Operating cash flow (CFO) was -$136.3M for H1 2025, improved from -$187.6M in H1 2024, but remained negative. The primary driver of the negative CFO was a large inventory build of $268.8M (change in inventory), partially offset by net income of $267.8M and non-cash items like depreciation ($114.8M) and gain on sale of assets ($226.1M). The company's capex of $423.2M (acquisition of leasing equipment and PP&E) resulted in negative free cash flow of -$559.5M. Despite this, dividends of $71.4M were paid. Investing cash flow was positive $496.1M, largely due to proceeds from asset sales ($589.3M + $397.1M from the 2025 Partnership). Financing activities used $173.1M, including dividend payments and preferred share redemption ($124.2M).
Anomalies: The substantial inventory increase ($268.8M) is a significant working capital outflow. The gain on sale of assets to the 2025 Partnership ($45.5M) and insurance recoveries ($54.3M) are non-recurring. The company's free cash flow deficit indicates heavy reliance on asset sales and debt to fund operations and growth.